ACL 1.32% $2.25 australian clinical labs limited

Yeah not ideal, but not a concern imo. It reads to me that the...

  1. 571 Posts.
    lightbulb Created with Sketch. 37
    Yeah not ideal, but not a concern imo. It reads to me that the debt facility is simply a matter of funding cashflow requirements. Any company that grows quickly has this problem. They are only paying out 57% of their NPAT as a dividend and their net leverage ratio is low, mix this with their strong forecast and I think shareholders shouldn't be concerned at this stage.

    https://hotcopper.com.au/data/attachments/5067/5067467-4b9385a65706b98cf5ff63d223c654b0.jpg
 
watchlist Created with Sketch. Add ACL (ASX) to my watchlist
(20min delay)
Last
$2.25
Change
-0.030(1.32%)
Mkt cap ! $454.1M
Open High Low Value Volume
$2.28 $2.28 $2.19 $1.902M 853.1K

Buyers (Bids)

No. Vol. Price($)
1 4672 $2.23
 

Sellers (Offers)

Price($) Vol. No.
$2.27 3500 1
View Market Depth
Last trade - 16.10pm 05/06/2024 (20 minute delay) ?
Last
$2.26
  Change
-0.030 ( 0.78 %)
Open High Low Volume
$2.28 $2.28 $2.20 141881
Last updated 15.59pm 05/06/2024 ?
ACL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.